Conference Proceedings
PATTERNS AND PREVALENCE OF IMMUNE-RELATED ADVERSE EVENTS AS DETECTED WITH FDG PET/CT IN PATIENTS TREATED WITH COMBINED CTLA-4 AND PD-1 INHIBITOR AS FIRST-LINE THERAPY FOR ADVANCED MELANOMA
A Iravani, MM Osman, MS Hofman, A Weppler, G Au-Yeung, S Sandhu, RJ Hicks
INTERNAL MEDICINE JOURNAL | WILEY | Published : 2019
